Wagner, J., Štibi, S., Selak, N., Alvir, I., Mamić, I., Marcelić, L. ... Danolić, D. (2023). Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer. Wiener Medizinische Wochenschrift, 173. (3-4), 57-61. doi: 10.1007/s10354-021-00907-w
Wagner, Jasenka, et al. "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer." Wiener Medizinische Wochenschrift, vol. 173, br. 3-4, 2023, str. 57-61. https://doi.org/10.1007/s10354-021-00907-w
Wagner, Jasenka, Sanela Štibi, Nikica Selak, Ilija Alvir, Ivica Mamić, Luka Marcelić, Lucija Šušnjar, Mario Puljiz, Marija Heffer i Damir Danolić. "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer." Wiener Medizinische Wochenschrift 173, br. 3-4 (2023): 57-61. https://doi.org/10.1007/s10354-021-00907-w
Wagner, J., et al. (2023) 'Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer', Wiener Medizinische Wochenschrift, 173(3-4), str. 57-61. doi: 10.1007/s10354-021-00907-w
Wagner J, Štibi S, Selak N, Alvir I, Mamić I, Marcelić L, i sur.. Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer. Wiener Medizinische Wochenschrift [Internet]. 2023. [pristupljeno 29.10.2024.];173(3-4):57-61. doi: 10.1007/s10354-021-00907-w
J. Wagner, et al., "Interleukin 10 rs1800896 and interleukin 1B rs16944 polymorphisms and the risk of cervical cancer", Wiener Medizinische Wochenschrift, vol. 173, br. 3-4, str. 57-61, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:220:505863. [Citirano: 29.10.2024.]